BORTOT, DANIEL C.AMORIM, BARBARA J.OKI, GLAUCIA C.GAPSKI, SÉRGIO B.SANTOS, ALLAN O.LIMA, MARIANA C.L.ETCHEBEHERE, ELB C.S.BARBOZA, MARYCEL F.MENGATTI, JAIRRAMOS, CELSO D.2014-07-312014-07-312014-07-312014-07-312012BORTOT, DANIEL C.; AMORIM, BARBARA J.; OKI, GLAUCIA C.; GAPSKI, SÉRGIO B.; SANTOS, ALLAN O.; LIMA, MARIANA C.L.; ETCHEBEHERE, ELB C.S.; BARBOZA, MARYCEL F.; MENGATTI, JAIR; RAMOS, CELSO D. sup(18)F-fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy. <b>European Journal of Nuclear Medicine and Molecular Imaging</b>, v. 39, n. 11, p. 1730-1736, 2012. Disponível em: http://repositorio.ipen.br/handle/123456789/8390.1619-7070http://repositorio.ipen.br/handle/123456789/83901730-1736openAccessaccuracycarcinomascomputerized tomographycystsdiagnosisfluoridesfluorine 18mammary glandsmetastable statespositron computed tomographyradiopharmaceuticalsscintiscanningsensitivityskeletal diseasesskeletonspecificityuptakeArtigo de periódico1139